Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05762588 · ClinicalTrials.gov registry record

JuggerKnot With Broadband PMCF Study

A clinical trial of Knee Injuries and Shoulder Injuries, sponsored by Riverpoint Medical.

Active
Registry status
30
Enrollment target
1
Study location

NCT05762588 is a study of Knee Injuries and Shoulder Injuries that is active but no longer recruiting, run by Riverpoint Medical. The registered enrollment target is 30 participants, below the 176-participant average among 14 other Knee Injuries trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05762588, a study of Knee Injuries and Shoulder Injuries, is active but no longer recruiting, sponsored by Riverpoint Medical.

ACTIVE NOT RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to collect post-market clinical follow-up data, which is needed to confirm the safety and performance of the JuggerKnot device and meet existing EU regulatory requirements.

Interventions

  • DEVICE Juggerknot with Broadband tape

Study Locations (1)

Maryland

  • MedStar Health Research Institute - Hyattsville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2023-11-30
Est. Completion 2025-12-30

Sponsor

Riverpoint Medical

1 total trials

What the Registry Record Tells You About NCT05762588

The ClinicalTrials.gov registry entry for NCT05762588 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 14 other Knee Injuries trials with a reported enrollment target (83% lower). The listed sponsor is Riverpoint Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Knee Injuries appearing as the primary indexed condition, and to 1 intervention - of which Juggerknot with Broadband tape is the first listed.

NCT05762588 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05762588 about?

NCT05762588 is a clinical study titled "JuggerKnot With Broadband PMCF Study". The purpose of the study is to collect post-market clinical follow-up data, which is needed to confirm the safety and performance of the JuggerKnot device and meet existing EU regulatory requirements.

What is the current status of trial NCT05762588?

This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2023-11-30. Estimated completion is 2025-12-30.

What conditions does trial NCT05762588 study?

This clinical trial studies the following conditions: Knee Injuries, Shoulder Injuries, Hip Injuries, Ankle Injuries, Foot Injury.

What interventions are being tested in trial NCT05762588?

The interventions under investigation include: Juggerknot with Broadband tape (DEVICE).

Who is sponsoring clinical trial NCT05762588?

This trial is sponsored by Riverpoint Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05762588 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.